A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions ; volume:20 ; number:1 ; day:18 ; month:2 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (18.2.2020), 1-9, 12.2020
- Creator
-
Kook, Hyungdon
Joo, Hyung Joon
Park, Jae Hyoung
Hong, Soon Jun
Yu, Cheol Woong
Lim, Do-Sun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-020-01381-9
- URN
-
urn:nbn:de:101:1-2020052801123207146065
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kook, Hyungdon
- Joo, Hyung Joon
- Park, Jae Hyoung
- Hong, Soon Jun
- Yu, Cheol Woong
- Lim, Do-Sun
- SpringerLink (Online service)
Other Objects (12)
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs